Acelrx Pharmaceuticals Inc. buy tamam
Start price
23.10.18
/
50%
€70.72
Target price
23.04.19
€131.69
Performance (%)
-13.27%
End price
23.04.19
€61.34
Summary
This prediction ended on 23.04.19 with a price of €61.34. The price of Acelrx Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -1.353% | -1.353% | 12.715% | -60.267% |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
(Laufzeit überschritten)
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.49
24.04.19
24.04.19
€117.26
04.11.21
04.11.21
-77.63%
05.11.21
05.11.21
